Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1292)
Immunome Inc. (IMNM)
Barchas Isaac — Director
Shares
24,335
Price
$23.33
Total Value
$567.74K
Shares Held After
208,504
% of Holdings
10.5%
Immunome Inc. (IMNM)
Barchas Isaac — Director
Shares
75,665
Price
$22.35
Total Value
$1.69M
Shares Held After
232,839
% of Holdings
24.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
225
Price
$556.36
Total Value
$125.18K
Shares Held After
45,172
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
990
Price
$555.83
Total Value
$550.27K
Shares Held After
45,397
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
299
Price
$554.45
Total Value
$165.78K
Shares Held After
46,387
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
2,201
Price
$553.52
Total Value
$1.22M
Shares Held After
46,686
% of Holdings
4.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,818
Price
$552.61
Total Value
$1.00M
Shares Held After
48,887
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,467
Price
$551.30
Total Value
$808.75K
Shares Held After
50,705
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
384
Price
$550.02
Total Value
$211.21K
Shares Held After
52,172
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
258
Price
$548.73
Total Value
$141.57K
Shares Held After
52,556
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
658
Price
$548.00
Total Value
$360.58K
Shares Held After
52,814
% of Holdings
1.2%
Neurogene Inc. (NGNE)
Cvijic Christine Mikail — Director
Shares
1,530
Price
$35.23
Total Value
$53.90K
Shares Held After
88,840
% of Holdings
1.7%
Neurogene Inc. (NGNE)
Cvijic Christine Mikail — Director
Shares
2,531
Price
$34.58
Total Value
$87.52K
Shares Held After
90,370
% of Holdings
2.7%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
11,008
Price
$23.56
Total Value
$259.37K
Shares Held After
13,579
% of Holdings
44.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$558.37
Total Value
$22.33K
Shares Held After
40,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$557.63
Total Value
$178.44K
Shares Held After
40,553
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,343
Price
$556.56
Total Value
$747.46K
Shares Held After
40,873
% of Holdings
3.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,942
Price
$555.67
Total Value
$1.63M
Shares Held After
42,216
% of Holdings
6.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,006
Price
$554.75
Total Value
$1.11M
Shares Held After
45,158
% of Holdings
4.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
776
Price
$553.64
Total Value
$429.62K
Shares Held After
47,164
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
993
Price
$552.72
Total Value
$548.86K
Shares Held After
47,940
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
640
Price
$551.59
Total Value
$353.02K
Shares Held After
48,933
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
118
Price
$549.77
Total Value
$64.87K
Shares Held After
49,573
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
130
Price
$548.75
Total Value
$71.34K
Shares Held After
49,691
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
192
Price
$548.01
Total Value
$105.22K
Shares Held After
49,821
% of Holdings
0.4%
Spyre Therapeutics, Inc. (SYRE)
Sloan Sheldon — Chief Medical Officer
Shares
1,834
Price
$88.34
Total Value
$162.02K
Shares Held After
0
% of Holdings
100.0%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
1,725
Price
$88.37
Total Value
$152.44K
Shares Held After
97,994
% of Holdings
1.7%
Spyre Therapeutics, Inc. (SYRE)
Sloan Sheldon — Chief Medical Officer
Shares
6,500
Price
$87.52
Total Value
$568.88K
Shares Held After
1,834
% of Holdings
78.0%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
5,775
Price
$87.55
Total Value
$505.60K
Shares Held After
99,719
% of Holdings
5.5%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
590
Price
$88.91
Total Value
$52.46K
Shares Held After
582,540
% of Holdings
0.1%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
4,234
Price
$88.12
Total Value
$373.10K
Shares Held After
583,130
% of Holdings
0.7%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
10,176
Price
$87.44
Total Value
$889.79K
Shares Held After
587,364
% of Holdings
1.7%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Gheuens Sarah — Chief Medical Officer
Shares
4,007
Price
$37.56
Total Value
$150.50K
Shares Held After
84,645
% of Holdings
4.5%
FENNEC PHARMACEUTICALS INC. (FENC)
Raykov Rosty — Former Director
Shares
9,599
Price
$10.41
Total Value
$99.93K
Shares Held After
138,855
% of Holdings
6.5%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
5,500
Price
$132.74
Total Value
$730.07K
Shares Held After
177,873
% of Holdings
3.0%
Shattuck Labs, Inc. (STTK)
Shukla Abhinav A. — Chief Technical Officer
Shares
100
Price
$7.07
Total Value
$707.00
Shares Held After
86,380
% of Holdings
0.1%
Royalty Pharma plc (RPRX)
Urist Marshall — EVP, Research & Investments
Shares
9,099
Price
$55.88
Total Value
$508.45K
Shares Held After
0
% of Holdings
100.0%
Orchestra BioMed Holdings, Inc. (OBIO)
Sherman Darren — Director
Shares
15,000
Price
$4.27
Total Value
$64.05K
Shares Held After
1,169,327
% of Holdings
1.3%
Septerna, Inc. (SEPN)
Long Daniel D. — SVP, Drug Discovery
Shares
1,233
Price
$34.81
Total Value
$42.93K
Shares Held After
96,412
% of Holdings
1.3%
Septerna, Inc. (SEPN)
Long Daniel D. — SVP, Drug Discovery
Shares
2,100
Price
$34.10
Total Value
$71.60K
Shares Held After
97,645
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
386
Price
$549.14
Total Value
$211.97K
Shares Held After
40,513
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,221
Price
$548.21
Total Value
$669.37K
Shares Held After
40,899
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
969
Price
$547.40
Total Value
$530.43K
Shares Held After
42,120
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,124
Price
$546.46
Total Value
$614.22K
Shares Held After
43,089
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
880
Price
$545.00
Total Value
$479.60K
Shares Held After
44,213
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$543.16
Total Value
$282.44K
Shares Held After
45,093
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
880
Price
$542.15
Total Value
$477.09K
Shares Held After
45,613
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
773
Price
$540.92
Total Value
$418.13K
Shares Held After
46,493
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,524
Price
$539.92
Total Value
$822.85K
Shares Held After
47,266
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
818
Price
$539.09
Total Value
$440.97K
Shares Held After
48,790
% of Holdings
1.6%
Showing 1–50 of 1292 transactions (page 1 of 26)